ampelopsin has been researched along with 4-phenylbutyric acid in 1 studies
| Studies (ampelopsin) | Trials (ampelopsin) | Recent Studies (post-2010) (ampelopsin) | Studies (4-phenylbutyric acid) | Trials (4-phenylbutyric acid) | Recent Studies (post-2010) (4-phenylbutyric acid) |
|---|---|---|---|---|---|
| 377 | 2 | 343 | 700 | 24 | 515 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, H; Liang, X; Mi, M; Peng, X; Shi, L; Shu, F; Zhou, Y; Zhu, J | 1 |
1 other study(ies) available for ampelopsin and 4-phenylbutyric acid
| Article | Year |
|---|---|
Ampelopsin induces cell growth inhibition and apoptosis in breast cancer cells through ROS generation and endoplasmic reticulum stress pathway.
Topics: Acetylcysteine; Activating Transcription Factor 6; Ampelopsis; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; eIF-2 Kinase; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Female; Flavonoids; Gene Expression Regulation, Neoplastic; Heat-Shock Proteins; Humans; Phenylbutyrates; Reactive Oxygen Species; RNA, Small Interfering; Signal Transduction; Thapsigargin; Transcription Factor CHOP; Transcription Factors | 2014 |